
William F McIntyre
@wfmmd
Electrophysiologist, Post-op CV Surgical MD @STJOESHAMILTON& @HamHealthSci, PhD @HEI_mcmaster, Investigator @PHRIResearch. Husband, Human & Dog Dad
ID: 456939652
06-01-2012 21:01:57
833 Tweet
794 Followers
132 Following


I am excited to present the 1st sub study from the The ARTESiA Trial 🇨🇦 at #EHRA2024 on Apr 9 in Berlin: Risk of stroke or systemic embolism according to baseline frequency and duration of subclinical #atrialfibrillation. What might SCAF pattern mean for clinical decision making?


#ICYMI: DOACs in Patients with Device-Detected AF #AHAJournals William F McIntyre @RenatoDLopes1 PHRI.ca Population Health Research Institute 🇨🇦 The ARTESiA Trial 🇨🇦 Mohammed Ali Alexander Benz

🚨4 LBCTs you don't want to miss #EHRA2024! Mon 13.15-14.15 1⃣Novel single shot PFA for PVI Vivek Y. Reddy 2⃣Cryoablation for monomorphic VT Atul Verma Tue 10.45-11.45 3⃣Insights form ARTESiA William F McIntyre 4⃣Pooled analysis of SMART-AV & SMART-CRT trials



🎉The results of the large intl B-FREE trial are out! PHRI Scientist Jessica Spence shared findings at #ACC2024: avoiding benzodiazepine use, may reduce the risk of postoperative delirium without increasing adverse events like intraoperative awareness. phri.ca/restricted-use…

Today I really enjoyed meeting, philosophizing and chatting with the John Mandrola, MD. We’ve done it a few times before digitally but never in person. Thanks to EHRAPresident #EHRA2024 for providing a great forum for the exchange of ideas.


Look who I got to meet while waiting for the train to #EHRA2024. Great to chat with you in person, Bogdan Enache



Important new data from The ARTESiA Trial 🇨🇦 presented by stroke neurologist Ashkan Shoamanesh at #ESOC2024. Pts with prior stroke and device-detected subclinical #AF have high stroke risk and get a large stroke-reduction benefit from apixaban PHRI.ca Population Health Research Institute 🇨🇦


From The ARTESiA Trial 🇨🇦 at #HRS2024 and in JACC Journals: Device-detected subclinical + CHA2DS2-VASc score >4: stroke risk 2.2%/yr. Clear benefit to OAC with apixaban No benefit with CHA2DS2-VASc score <4. Grey zone at CHA2DS2-VASc =4. PHRI.ca Population Health Research Institute 🇨🇦 Duke Clinical Research Institute

I’m proud to mentor you Hargun Kaur! I can’t wait to see what you are going to do next!

In the ARTESiA trial 🔸31% of pts with AHRE progressed to clinical #AFib or AHRE >24h 🔸Outcome predictors: order age, HF, male sex, LA dilation, AHRE >1h Boriani Giuseppe William F McIntyre PHRI.ca Population Health Research Institute 🇨🇦 The ARTESiA Trial 🇨🇦 European Society of Cardiology Journals Dominik Linz David Duncker #ESCCongress


TInternational Arrhythmia School 2025! This is your opportunity to join leading experts and enhance your knowledge in arrhythmia and electrophysiology. 📅 Dates: Feb 7-9, 2025 📍 Location: Collingwood Conference Centre, Ontario Register winterarrhythmia.com Eugene Crystal MD FRCPC

🚨 FLASH SALE ALERT 🚨 Fellows, don’t miss out! Register for Arrhythmia Update 2025 at 50% off when you email [email protected] before Dec 23rd! For more information -> arrhythmiaupdate.ca Act fast to secure your spot! #AU25 #FellowsDiscount #Cardiology #MedicalEducation



Looking forward to being back at Winter Arrhythmia in January.
